Posted Yesterday Up to two decades before people develop the characteristic memory loss and confusion of Alzheimer’s disease, damaging clumps of protein start to build up in their brains. Now, a blood test to detect such early brain changes has moved one step closer to clinical use. Researchers from Washington University School of Medicine in St. Louis report that they...
Tag: <span>aged disease</span>
Post
Montmorency tart cherry juice may help improve cognitive performance in older adults
Reviewed by Kate Anderton, B.Sc. (Editor) Montmorency tart cherry juice has long been coveted by gout sufferers, athletes for exercise recovery, and those seeking a good night’s sleep. Now there’s evidence that this polyphenol-rich beverage may help improve cognitive performance in older adults. In a new study published in the journal Food & Function, researchers...
Post
ASCT may offer alternative for therapy for high-risk follicular lymphoma
Ana Jiménez-Ubieto, M.D., Ph.D., from the Hospital Universitario 12 de Octubre in Madrid, and colleagues examined whether ASCT is an effective option in the pre-rituximab era for patients treated in induction and rescued only with chemotherapy. Two groups were identified: the ETF cohort (87 patients) and the non-ETF cohort (47 patients). The researchers found that five-year progression-free...
Post
Scientists link frequent use of sleep medication with changes to risk of developing dementia
by Alzheimer’s Research UK Many older adults who have trouble sleeping take medication to help them sleep. New research, presented at the Alzheimer’s Association International Conference 2019, suggests certain groups of people who take sleep medication may be at a higher risk of developing dementia. Two different studies have investigated the link between sleep medication and...
Post
Muscle-wasting sarcopenia is now a recognised disease—but we can all protect ourselves
by Robin Daly And Andrea B. Maier, The Conversation As we grow older, the size and strength of our muscles progressively deteriorates. This can affect our capacity to perform everyday activities like standing up from a chair, climbing stairs or carrying groceries. For some people, muscle wasting becomes more severe, leading to falls, frailty, immobility and a loss of autonomy. People who experience...
Post
COULD GENE MODIFICATION BE A SKELETON KEY FOR CURING ALZHEIMER’S?
While CRISPR technology is generating a new wave of optimism for curing neurological diseases, experts warn that it has to be one part of a larger approach. TARA FERNANDEZ It’s hard to ignore the fanfare. CRISPR and other genome-editing technologies are set to redefine the way we treat a vast array of illnesses, from cancer to inherited...
Post
MS patients at a greater risk of cancer, new study suggests
New results of a 65-year follow-up study of nearly 7,000 Norwegian patients with multiple sclerosis (MS) suggest that patients may have a greater overall risk of developing cancer than the general population SPINK HEALTH (Oslo, Saturday, 29 June, 2019) New results of a 65-year follow-up study of nearly 7,000 Norwegian patients with Multiple Sclerosis (MS) suggest that patients may have a greater overall risk of developing cancer than the general population, with an especially high risk of cancer in respiratory organs, urinary organs and the central...
Post
Scientists map elusive toxic proteins linked to Alzheimer’s, providing new molecular clues for prevention
A team of researchers from McMaster University has mapped at atomic resolution a toxic protein linked to Alzheimer’s disease, allowing them to better understand what is happening deep within the brain during the earliest stages of the disease. The findings, published on the front cover of the current edition of the Royal Society of Chemistry flagship journal Chemical Science, provide new insights...
Post
Opioid analgesics increase the risk of pneumonia among persons with Alzheimer’s disease
by University of Eastern Finland Opioid analgesics were associated with a 30 percent increase in the risk of pneumonia in persons with Alzheimer’s disease, a recent study from the University of Eastern Finland shows. The risk was most pronounced in the first two months of use. This is the first study to investigate the association between opioids and pneumonia in this population. The results were published in the Journal of Alzheimer’s Disease. The risk of pneumonia was highest among those...
Post
Researchers block protein that plays a key role in Alzheimer’s disease
by Lund University In recent years, it has become increasingly clear to researchers that the protein galectin-3 is involved in inflammatory diseases in the brain. A study led by researchers at Lund University in Sweden now shows the de facto key role played by the protein in Alzheimer’s disease. When the researchers shut off the gene that produces this protein in mice, the amount of Alzheimer’s plaque and the inflammatory load both decreased. Researchers at Lund...